Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Apricus Biosciences Inc announces national phase approval for Vitaros in Spain

Thursday, 24 Apr 2014 08:00am EDT 

Apricus Biosciences Inc:Spanish Agency for Medicines and Health Products has granted national phase approval to Vitaros, Apricus' novel topical on-demand treatment for erectile dysfunction.With approval in Spain, Company has now received total of ten national phase approvals for Vitaros. 

Company Quote

-0.23 -8.95%
26 Feb 2015